Register
Forgot your password?

Problems of diagnosing non-ST-segment elevation myocardial infarction in patients with chronic kidney disease

Authors: Kremneva L.V. 1 2

Company: 1 Tyumen State Medical University of the Ministry of Health of Russia, Tyumen, Russian Federation
2 Tyumen Cardiology Research Center, Tomsk National Research Medical Center of the Russian Academy of Sciences, Tyumen, Russian Federation

For correspondence:  Sign in or register.

Type:  Reviews


DOI: https://doi.org/10.24022/1997-3187-2026-20-2-200-207

For citation: Kremneva L.V. Problems of diagnosing non-ST-segment elevation myocardial infarction in patients with chronic kidney disease. Creative Cardiology. 2026; 20 (2): 200–207 (in Russ.). DOI: 10.24022/1997-3187-2026-20-2-200-207

Received / Accepted:  06.04.2026 / 20.04.2026

Keywords: non-ST-segment elevation myocardial infarction high-sensitivity troponin tests chronic kidney disease



Subscribe 🔒

 

Abstract

The review presents the results of studies showing an increased risk of non-ST-segment elevation myocardial infarction (NSTEMI) in patients with chronic kidney disease (CKD). However, there are still some difficulties in diagnosing this condition in patients of this group. Atypical symptoms of the disease, nonspecific changes in the ST segment and T wave on the electrocardiogram, and initially elevated levels of high-sensitivity cardiac troponins (hs-cTn) are the reasons for late diagnosis and suboptimal treatment of NSTEMI in patients with CKD. High levels of hs-cTn in patients with NSTEMI and CKD are associated with a poor cardiovascular prognosis. It has been shown that hs-cTn testing can maintain its high diagnostic accuracy in patients with CKD when optimized threshold values are used in short algorithms. Optimal threshold levels should be individually determined for each test produced by different companies. Currently, there is no unified algorithm for confirming or excluding NSTEMI using hs-cTn in patients with CKD.

References

  1. Thygesen K., Alpert J.S., Jaffe A.S., et al. ESC Scientific Document Group. Fourth universal definition of myocardial infarction (2018). Circulation. 2018; 138. DOI: 10.1161/CIR.0000000000000617.
  2. Roffi M., Patrono C., Collet J.P. et al. Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-segment Elevation of the European Society of Cardiology. 2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur. Heart J. 2016; 37: 267–315. DOI: 10.1093/eurheartj/ehv320.
  3. Mills N.L., Churchhouse A.M., Lee K.K. et al. Implementation of a sensitive troponin I assay and risk of recurrent myocardial infarction and death in patients with suspected acute coronary syndrome. JAMA. 2011; 305 (12): 1210–1216. DOI: 10.1001/jama.2011.338.
  4. Fox C.S., Muntner P., Chen A.Y. et al. Use of evidence-based therapies in short-term outcomes of ST-segment elevation myocardial infarction and non-ST-segment elevation myocardial infarction in patients with chronic kidney disease: A report from the National Cardiovascular Data Coronary Treatment and Intervention Outcomes Network registry. Circulation. 2010; 121: 357–365. DOI: 10.1161/CIRCULATIONAHA.109.865352.
  5. Fujii H., Kono K., Nishi S. Characteristics of coronary artery disease in chronic kidney disease. Clin. Nephrol. 2019; 23 (6): 725–732. DOI: 10.1007/s10157-019-01718-5.
  6. Ohtake T., Kobayashi S., Moriya H. et al. High prevalence of occult coronary artery stenosis in patients with chronic kidney disease at the initiation of renal replacement therapy: an angiographic examination. J. Am. Soc. Nephrol. 2005; 16 (4): 1141–1148. DOI: 10.1681/ASN.2004090765.
  7. Valdivielso J.M., Rodriguez-Puyol D., Pascual J. et al. Atherosclerosis in chronic kidney disease: more, less, or just different? Arterioscler. Thromb. Vasc. Biol. 2019; 39 (10): 1938–1966. DOI: 10.1161/ATVBAHA.119.312705.
  8. Koukoulaki M., Papachristou E., Kalogeropoulou C. et al. Increased prevalence and severity of coronary artery calcification in patients with chronic kidney disease stage III and IV. Nephron Extra. 2012; 2 (1): 192–204. DOI: 10.1159/000339786.
  9. Rzhevskaya O.N., Moisejeva A.Yu., Esaulenko A.N. et al. Chronic Kidney Disease and Myocardial Infarction. Russian Sklifosovsky Journal of Emergency Medical Care. 2022; 11 (1): 104–108 (in Russ.). DOI: 10.23934/2223-9022-2022-11-1-104-108.
  10. Brugts J.J., Knetsch A.M., Mattace-Raso F.U. et al. Renal function and risk of myocardial infarction in elderly population: the Rotterdam study. Arch. Intern. Med. 2005; 165 (22): 2659–2665. DOI: 10.1001/archinte.165.22.2659.
  11. Peng Y., Du X., Li X. et al. Association of renal insufficiency with treatments and outcomes in patients with acute coronary syndrome in China. Int. J. Cardiol. 2021; 323: 7–12. DOI: 10.1016/j.ijcard.2020.08.022.
  12. Sakhuja A., Wright S., Schold J. et al. National impact of maintenance dialysis or renal transplantation on outcomes following ST-elevation myocardial infarction. Am. J. Nephrol. 2016; 44: 329–338.
  13. Kuipers J., Verboom L.M., Ipema K.J. The prevalence of intradialytic hypotension in patients on conventional hemodialysis. A systematic review with meta-analysis. Am. J. Nephrol. 2019; 49 (6): 497–506. DOI: 10.1159/000500877.
  14. Jeon H.J., Oh J., Lee Y.K. Static intra-access pressure ratio cardiovascular events in patients undergoing haemodialysis. Scientific Reports. 2021; 10 (1): 1–8. DOI: 10.1038/s41598-020-58190-5.
  15. den Dekker W.K., Slot M.C., Kho M.M.L. et al. Predictors of postoperative cardiovascular complications up to 3 months after kidney transplantation. Neth. Heart J. 2021; 28 (4): 202–209. DOI: 10.1007/s12471-020-01373-6.
  16. Kasiske B.L., Maclean I.R., Snyder J.J. Acute Myocardial Infarction and Kidney Transplantation. J. Am. Soc. Nephrol. 2006; 17 (3): 900–907. DOI: 10.1681/ASN2005090984.
  17. Gradaus F., Ivents K., Peters A.S. et al. Angiographic progression of coronary artery disease in patients with end-stage renal disease. Nephrol. Dial. Transplant. 2001; 16 (6): 1198–1202. DOI: 10.1093/ndt/16.6.1198.
  18. Shroff G.R., Frederick P.D., Herzog C.A. Renal failure and acute myocardial infarction: clinical characteristics in patients with advanced chronic kidney disease, on dialysis, and without chronic kidney disease: a collaborative project of the United States Renal Data System National Institutes of Health and the National Registry of Myocardial Infarction. Am. Heart J. 2012; 163 (3): 399–406. DOI: 10.1016/j.ahj.2011.12.002.
  19. Potier L., Roussel R., Zeller M. et al. Chronic kidney disease, diabetes, and risk of mortality after acute myocardial infarction: insight from the FAST-MI program. Diabetes Care. 2021; 43 (3): e43–e44. DOI: 10.2337/dc19-2209.
  20. Dubin R.F., Li Y., He J. et al. Predictors of high sensitivity cardiac troponin T in chronic kidney disease patients: a cross-sectional study in the chronic renal insufficiency cohort (CRIC). BMC Nephrology. 2013; 14: 229. DOI: 10.1186/1471-2369-14-229.
  21. Li Z., Tao J., Wang H. et al. High-sensitivity cardiac troponin I in the diagnosis of acute myocardial infarction: A study in patients with renal insufficiency. Am. Heart J. Plus. 2025; 4 (59): 100631. DOI: 10.1016/j.ahjo.2025.100631.
  22. Banerjee D., Perret C., Banerjee A. Troponins, acute coronary syndromes and renal disease: from acute kidney injury through end-stage kidney disease. Eur. J. Cardiol. 2019; 14: 187–190. DOI: 10.15420/ecr.2019.28.2.
  23. Newby L.K., Jesse R.L., Babb J.D. et al. ACCF 2012 expert consensus document on practical clinical considerations in the interpretation on troponin elevations: a report of the American College of Cardiology Foundation task force on Clinical Expert Consensus Documents. J. Am. Coll. Cardiol. 2012; 60: 2427–2463. DOI: 10.1016/j.jacc.2012.08.969.
  24. Twerenbold R., Badertscher P., Boeddinghaus J. et al. 0/1 Hour triage algorithm for myocardial infarction in patients with renal dysfunction. Circulation. 2018; 137: 436–451. DOI: 10.1161/CIRCULATIONAHA.117.028901.
  25. Kraus D., von Jeinsen B., Tzikas S. et al. Cardiac troponins for the diagnosis of acute myocardial infarction in chronic kidney disease. J. Am. Heart Assoc. 2018; 7: e008032. DOI: 10.1161/JAHA.117.008032.
  26. Guler E.E., Payza U., Kayali A. et al. Troponin efficacy in the diagnosis of acute coronary syndrome in patients with chronic renal failure. Medicine (Baltimore). 2024; 103 (9): e37280. DOI: 10.1097/MD.0000000000037280.
  27. Alushi B., Jost-Brinkmann F., Kastrati A. et al. High-sensitivity cardiac troponin T in patients with severe chronic coronary syndrome. J. Clin. Med. 2021; 10 (18): 4216. DOI: 10.3390/jcm10184216.
  28. Jang H., Lui J., Luo H. et al. Improving the diagnostic accuracy of acute myocardial infarction with the use of high-sensitive cardiac troponin T in different chronic kidney disease stages. Sci. Rep. 2017; 7: 41350. DOI: 10.1038/srep41350.
  29. Twerenbold R., Wildi K., Jaeger C. et al. Optimal cutoff levels of more sensitive cardiac troponin assays for the early diagnosis of myocardial infarction in patients with renal dysfunction. Circulation. 2015; 131 (23): 2041–2050. DOI: 10.1161/CIRCULATIONAHA.114.014245.

About Authors

Lyudmila V. Kremneva, Dr. of Med. Sci., Professor1 2, Senior Researcher2; ORCID

Chief Editor

Elena Z. Golukhova, MD, PhD, DSc, Professor, Academician of Russian Academy of Sciences, Director of Bakoulev National Medical Research Center for Cardiovascular Surgery


Sort by